817 related articles for article (PubMed ID: 3142681)
1. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
2. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
Kruszewski FH; Conti CJ; DiGiovanni J
Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733
[TBL] [Abstract][Full Text] [Related]
3. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919
[TBL] [Abstract][Full Text] [Related]
4. Promoter independence as a feature of most skin papillomas in SENCAR mice.
Aldaz CM; Conti CJ; Chen A; Bianchi A; Walker SB; DiGiovanni J
Cancer Res; 1991 Feb; 51(3):1045-50. PubMed ID: 1899044
[TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
Scribner JD; Scribner NK; McKnight B; Mottet NK
Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
8. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
[TBL] [Abstract][Full Text] [Related]
9. NTP Comparative Initiation/Promotion Skin Paint Studies of B6C3F1 Mice, Swiss (CD-1(R)) Mice, and SENCAR Mice.
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Feb; 441():1-201. PubMed ID: 12595922
[TBL] [Abstract][Full Text] [Related]
10. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
Iversen OH
APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
[TBL] [Abstract][Full Text] [Related]
11. Dietary fat effects on the initiation and promotion of two-stage skin tumorigenesis in the SENCAR mouse.
Birt DF; White LT; Choi B; Pelling JC
Cancer Res; 1989 Aug; 49(15):4170-4. PubMed ID: 2472874
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of mouse skin tumor promotion by chrysarobin.
DiGiovanni J; Decina PC; Prichett WP; Cantor J; Aalfs KK; Coombs MM
Cancer Res; 1985 Jun; 45(6):2584-9. PubMed ID: 3986797
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice.
Gimenez-Conti IB; Bianchi AB; Fischer SM; Reiners JJ; Conti CJ; Slaga TJ
Cancer Res; 1992 Jun; 52(12):3432-5. PubMed ID: 1375869
[TBL] [Abstract][Full Text] [Related]
14. Regression and progression characteristics of papillomas induced by chrysarobin in SENCAR mice.
Battalora MS; Conti CJ; Aldaz CM; Slaga TJ; Johnston DA; DiGiovanni J
Carcinogenesis; 1996 May; 17(5):955-60. PubMed ID: 8640943
[TBL] [Abstract][Full Text] [Related]
15. Further studies on the influence of initiation dose on papilloma growth and progression during two-stage carcinogenesis in SENCAR mice.
DiGiovanni J; Walker SE; Aldaz CM; Slaga TJ; Conti CJ
Carcinogenesis; 1993 Sep; 14(9):1831-6. PubMed ID: 8403206
[TBL] [Abstract][Full Text] [Related]
16. The protein kinase C activator L-alpha-dioctanoylglycerol: a potent stage II mouse skin tumor promoter.
Verma AK
Cancer Res; 1988 Apr; 48(7):1736-9. PubMed ID: 3127039
[TBL] [Abstract][Full Text] [Related]
17. Induction of terminal differentiation-resistant epidermal cells in mouse skin and in papillomas by different initiators during two-stage carcinogenesis.
Miller DR; Viaje A; Rotstein J; Aldaz CM; Conti CJ; Slaga TJ
Cancer Res; 1989 Jan; 49(2):410-4. PubMed ID: 2491955
[TBL] [Abstract][Full Text] [Related]
18. The reverse experiment in two-stage skin carcinogenesis. It cannot be genuinely performed, but when approximated, it is not innocuous.
Iversen OH
APMIS Suppl; 1993; 34():1-96. PubMed ID: 8251199
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of 1,2-Dihydro-2,2,4-Trimethylquinoline (CAS No. 147-47-7) in F344/N Rats and B6C3F1 Mice (Dermal Studies) and the Dermal Initiation/Promotion Study in Female Sencar Mice.
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 Feb; 456():1-312. PubMed ID: 12587020
[TBL] [Abstract][Full Text] [Related]
20. beta-Carotene fails to act as a tumor promoter, induces RAR expression, and prevents carcinoma formation in a two-stage model of skin carcinogenesis in male Sencar mice.
Ponnamperuma RM; Shimizu Y; Kirchhof SM; De Luca LM
Nutr Cancer; 2000; 37(1):82-8. PubMed ID: 10965524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
